Insight Molecular Diagnostics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| IMDX | BDSX | GDR.L | NEO | PSNL | MYGN | |
|---|---|---|---|---|---|---|
| Market cap | 86.72M | 226.74M | 15.29M | 2.22B | 1.69B | 575.81M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -3.3 | -97.7 | 0.0 | 54.5 | -16.3 | -10.2 |
| Price/book | -4.1 | 24.8 | — | 2.8 | 6.2 | 1.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −58.86% | +144.77% | +1.60% | +61.36% | +119.76% | −4.90% |
| Today | −3.28% | +2.09% | −2.31% | +1.90% | +0.25% | −0.33% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 15 min.
Latest news
All IMDX news ›CareDx Announces Third KOAR Analysis Published in Transplantation
Rising Dragon Acquisition Corp. and HZJL Cayman Limited Announce Mutual Termination of Merger Agreement Cipher, a Prosegur Company, and BIO-key Announce Technology Integration to Expand Identity Security Offering, Starting in Portugal…
Opus IVS announces new senior sales leader for insurer and MSO relationships
Quintin Paredes joins the team as demand for diagnostic solutions grows in response to vehicle technological advancements Detroit—Opus IVS has announced Quintin Paredes as Vice President of Insurer Relationships and Strategic Accounts.…
Analysts Conflicted on These Healthcare Names: Insight Molecular Diagnostics (IMDX), Tandem Diabetes Care (TNDM) and Odyssey Therapeutics, Inc. (ODTX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Insight Molecular Diagnostics (IMDX), Tandem Diabetes Care (TNDM) and Odyssey Therapeutics, Inc. (ODTX). In a report released yesterday, Mark Massaro from…
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
The event will provide an overview of GraftAssure, currently under review by the FDA to be commercialized in kitted form for labs to test patients for kidney transplant rejection. Dr. Liebo will discuss how a kitted GraftAssure test…
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
Study published by Lancet Regional Health helps doctors manage new class of drugs for kidney transplant patients suffering organ rejectionSerial m... iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet…
Transcript : Insight Molecular Diagnostics Inc., Q2 2026 Earnings Call, Aug 10, 2026
Presenter SpeechGabrielle Woody Welcome, everyone, and thank you for joining us to discuss Insight Molecular Diagnostics' second quarter 2026 results. If you have not seen today's shareholder Insight Molecular Diagnostics Inc. Transcript :…
Transcript : Insight Molecular Diagnostics Inc. - Special Call
Presentation Operator MessageOperator Good morning, and welcome to the Insight Molecular Diagnostics Virtual KOL event. [Operator Instructions] As a reminder, this call is being recorded, and a Insight Molecular Diagnostics Inc. Transcript…
Insight Molecular Diagnostics Announces GraftAssure Platform And GraftAssureDx Test For Transplanted Organ Health Monitoring
Insight Molecular Diagnostics Inc. announced that it will host a virtual key opinion leader event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD , who will join Nick Ioannou, MD,... Insight Molecular Diagnostics Inc…
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
NASHVILLE, Tenn., July 16, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today highlighted a favorable new Medicare policy supporting expanded coverage for donor-derived cell-free DNA (dd-cfDNA)…
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
NASHVILLE, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report second quarter 2026 financial results after the market closes on Monday, August 10, 2026.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com8
- markets.businessinsider.com6
- aftermarketmatters.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.